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Challenges for chemoinformatics
education in drug discovery
David J. Wild and Gary D. Wiggins
School of Informatics, Indiana University, 901 E 10th Street, Bloomington, IN 47408, USAChemoinformatics is rapidly becoming a core part of drug design informatics, yet the educational
opportunities in the field are currently limited. This article reviews the academic and commercial
educational programs that are available in chemoinformatics, considers the current challenges and takes
a look at emerging trends, such as distance education and intensive short courses.Like many of today’s emerging life science fields, chemoinfor-
matics has become a ‘hot topic’ while it is still in the process of
finding its identity. Indeed it is not yet clear how to spell the name
of the field: some prefer cheminformatics – no ‘o’ – and others,
including ourselves, use entirely different terms, such as chemical
informatics. What is clear is that the techniques that this field
concerns itself with – the processing of chemical and related
information on computers – are becoming central to the processes
of modern drug discovery [1].
The use of computers for the processing of chemical informa-
tion had its origins in various scientific and computer-related
disciplines, as well as some pioneering academic work, such as
that at the University of Sheffield, UK, in the late 1960s on the
representation and use of chemical structure information. For
many years, the field of chemical-information handling had a
well-defined and important part to play in library and information
systems, where the techniques were used for the storage and
searching of chemical and patent databases. In addition, compu-
tational chemistry methods were applied to aid understanding of
theoretical chemistry and pharmaceutical drug discovery where a
variety of techniques, such as similarity searching and docking,
helped scientists find potentially active molecules and model how
those molecules bind to protein targets in the body. This latter
application, known as computer-aided drug design or molecular
modeling, rapidly became an essential part of modern drug dis-
covery, and thus the pharmaceutical industry became a strong
supporter of the field. In particular, the race to develop antiretro-
viral drugs for AIDS resulted in a strong push to use computational
techniques to speed up the discovery of new drugs, and theCorresponding author: Wild, D.J. (djwild@indiana.edu)
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can be traced directly to the application of computer-aided drug
design [2]. It is important to recognize that despite its strong
support from the pharmaceutical industry, the field, unlike other
life-science-related computer disciplines, also has strong support
and application outside the life sciences arena.
During the mid to late 1990s, the technological innovations
that began to impact the processes of early stage drug discovery
resulted in a vast increase in the amount of chemical information
available. HTS enabled hundreds of thousands of compounds to be
screened for biological activity in a short period of time, and
combinatorial chemistry enabled the automatic synthesis of thou-
sands of new structural analogs at once. Likewise, improvements
in X-ray crystallography and NMR spectroscopy meant that the
number of proteins with resolved 3D structures increased drama-
tically, and new experimental pharmacology and toxicity meth-
ods led to a dramatic increase in useful information about the
effects of drugs in the body. More recently, the advent of genomics
and particularly microarray assays has meant that cellular samples
(including those treated with chemical compounds) can be tested
for up- or down-regulation of thousands of genes at once. There-
fore, Modern-day early-stage drug discovery involves the genera-
tion of vast amounts of pertinent data from a diverse set of sources.
However, effectively managing, organizing and analyzing that
data can be extremely difficult, particularly because the volumes
are much more than can be analyzed manually. There is therefore
much demand for techniques that allow the data to be turned into
useful information and knowledge [3].
Demand is also increasing for people who have training and
experience in these techniques. However, there is still only a very
small number of academic institutions that offer teaching andee front matter  2006 Elsevier Ltd. All rights reserved. doi:10.1016/j.drudis.2006.03.010
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Squalifications in chemoinformatics or related disciplines, and
these institutions generally only offer substantial graduate courses
that require relocation to the site of the institution and a time
commitment that is incompatible with maintaining parallel full-
time employment.
Academic programs in chemoinformatics
A small number of universities have established chemoinformatics
programs [4–6]. The most widely recognized and well-established
research and teaching base in the field is the Department of
Information Studies at the University of Sheffield, which offers
Master of science (MSc, or MS) degree and PhD qualifications in
chemoinformatics. Subsequent programs have been developed at
the University of Manchester Institute of Science and Technology
(UMIST), now merged with the University of Manchester, UK, and
the School of Informatics at Indiana University (IU), IN, USA. The
programs offered by the institutions, and their URLs, are summar-
ized in Table 1.
University of Sheffield
At Sheffield, the Master of Science (MSc, or MS) program includes
courses in database design, information searching and retrieval,
principles of chemoinformatics, foundations of object-oriented
programming, research methods and dissertation preparation, and
a dissertation in chemoinformatics. Sheffield also offers periodic
intensive short courses in chemoinformatics, which emphasize
practical chemoinformatics skills including 2D databases and
database searching, diversity and compound selection, QSAR,
computational methods for 3D, 3D databases, combinatorial
libraries, and analysis of HTS data.
University of Manchester
At the University of Manchester, the MSc course has been devel-
oped (originally created at UMIST before their merger) in the
School of Chemistry, in conjunction with sponsors from the
chemical informatics community. Core modules include research
methodology and feasibility study, chemical information sources,
molecular simulation and design, spectroscopy and crystallogra-
phy in cheminformatics, database design and programming, che-
minformatics applications, and fundamentals of bioinformatics.
There is also a Master of Enterprise (MEnt) degree at the Manche-
ster Science Enterprise Centre, which offers the opportunity to
combine chemoinformatics and business courses.
Indiana University
The Indiana University School of Informatics has programs in
many areas of science informatics, including bioinformatics andTABLE 1
Institutions offering academic programs in chemoinformaticsa
Institution and web address Masters degree
University of Sheffield Department of Information Studies
(www.shef.ac.uk/is)
U
Indiana University School of Informatics
(www.informatics.indiana.edu)
U
University of Manchester School of Chemistry
(www.chemistry.manchester.ac.uk)
U
a Institutions offering only PhD programs are excluded.chemical informatics, at the Bloomington (IUB) and Indianapolis
(IUPUI) campuses. In addition, IUPUI has MS graduate programs
in laboratory informatics and health informatics and a developing
medical informatics program, plus a Bachelor of Science (BS)
undergraduate program in health information administration.
The School has a variety of opportunities for training in chemical
informatics for undergraduate and graduate students, including a
BS in informatics with a cognate in chemistry, an MS in chemical
informatics, and a PhD in informatics with a track in chemical
informatics. Core chemoinformatics courses for these programs
include: chemical information technology, computational chem-
istry and molecular modeling, programming for science infor-
matics and an independent study module, with other required
courses in introductory informatics and information manage-
ment. MS students must complete a substantial capstone project.
Since the first year they were taught, in 2001, the core chemical-
informatics courses have used remote conferencing technology to
allow participation from several sites, and they are now offered to
any US-resident graduate as part of a distance-education chemical
informatics certificate program. The classes are carried out live on
the internet, currently using the Raindance meeting edition web
conferencing system (www.raindance.com).
Other institutions
There is evidence of increasing interest in the creation of che-
moinformatics programs at other institutions. The Beilstein Insti-
tute has funded an endowed chair for chemoinformatics at Johann
Wolfgang Goethe University of Frankfurt, Germany (http://gec-
co.org.chemie.uni-frankfurt.de), and Unilever has funded the
Centre for Molecular Informatics at the University of Cambridge,
UK (http://www-ucc.ch.cam.ac.uk). The Department of Computer
Science at the University of Massachusetts, Lowell, USA, has
created both an undergraduate and MS program in bio- and
chem-informatics (http://cs.uml.edu).
There is a one-year postgraduate distance-education diploma
program at the Institute of Cheminformatics Studies in Noida, India
(www.cheminformaticscentre.org/files/index.asp). A pharmaco-
chemistry MS degree can be obtained from the University of Stras-
bourg, France (http://bioinfo-pharma.u-strasbg.fr/education.php),
and at the Friedrich Alexander University of Erlangen–Nuremberg,
Germany, chemoinformatics is part of the course on molecular
science (www2.chemie.uni-erlangen.de/education/cheminf).
Michigan Technological University, USA now offers a BS
in Cheminformatics (www.chemistry.mtu.edu/pages/undergrad/
index.php). Several undergraduate institutions list chemoinfor-
matics as possible areas of specialization, for example, Rensselaer
Polytechnic Institute, NY, USA, has a science IT concentrationPhD Certificate Short courses Distance learning
U U
U U U
U U
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do?artcenterkey=19andsetappvar=page(1)), and at the University
of Pittsburgh, Bradford, PA, USA, a molecular informatics BS was
proposed in the 2004–2005 academic year. A BS in molecular
informatics, which is essentially the art of organizing and accessing
vast amounts of molecular data, would provide graduates with the
opportunity to pursue advanced study in such areas as proteomics,
bioinformatics, chemoinformatics, drug design, computational
chemistry and molecular biology. Graduates would also be prepared
for technical positions in the pharmaceutical industry.
Other institutions that do not have formal programs still con-
tributed to learning in the field of chemoinformatics. For example,
although it was never continued beyond pilot stage, an interesting
program was developed at the University of Nottingham, UK, in
conjunction with Pfizer called the Virtual School of Molecular
Sciences, which established an internet-based course on structure-
based drug design.
The academic activities in this field have also spawned a small
number of textbooks. Of particular note are Leach and Gillet’s
very accessible and readable An Introduction to Chemoinformatics
[7], Gasteigher and Engel’s comprehensive Chemoinformatics: A
Textbook [8] and the multi-volume Handbook of Chemoinformatics
[9].
Commercial offerings
Chemoinformatics education has not seen much uptake in the
commercial sector, although there are a few offerings which stand
out. Molecular Conceptor (www.molecular-conceptor.com) have a
computer-based course for teaching the fundamentals of medicinal
chemistry, drug design, molecular modeling and chemoinformatics
for universities and Industry. According to their website, the course
is currently used by more than 200 academic institutions world-
wide. Included in the course are modules on molecular modeling,
protein structure and modeling, rational drug design, structure- and
pharmacophore-based drug design, QSAR, synthesis and library
design, peptidomimetics, ADME properties and predictions, and
database searching. Mesa Analytics and Computing (www.mesaac.
com) recently won a Phase II small-business innovation research
(SBIR) grant to develop web-based teaching tools for chemoinfor-
matics, and it is likely that these tools will be used to form a ‘virtual
classroom’ for teaching chemoinformatics. Network Science Cor-
poration offer a brief, but free, set of introductory course materials
(www.netsci.org/courseware) focusing on drug design.
Historically, some of the chemoinformatics conferences, parti-
cularly the more intimate corporate ones like the Daylight MUG
(www.daylight.com) and OpenEye CUP (www.eyesopen.com),
have also served as informal places of learning about chemoinfor-
matics in general. Several companies arrange more formal short
courses and conferences that focus on particular areas of life
sciences, including chemoinformatics, and which serve as inten-
sive learning opportunities in the field. Most notable have been
Cambridge Healthtech (www.healthtech.com) and more recently
eChemInfo (http://echeminfo.colayer.net).
A look to the future
The future of the field of chemoinformatics is still in flux and is, of
course, dependent on the directions that life science research
takes. The pharmaceutical industry is still a major driver in the438 www.drugdiscoverytoday.comfield, but the growing open-source movement [10,11] and govern-
ment sponsorship of chemoinformatics programs, such as Pub-
Chem [12], is helping to broaden the accessibility and use of
chemoinformatics tools and techniques. The increase in external
licensing deals for drugs by pharmaceutical companies (as opposed
to research being primarily internal to the company) is likely to
result in more support for smaller, corporate or university drug-
development research units, and thus a demand for affordable
chemoinformatics tools for these groups, and a corresponding
need for education in chemoinformatics techniques. Moreover,
the vibrant young pharmaceutical industries developing in India
and China are clearly going to be technology-focused, with com-
putational specialties like chemoinformatics and bioinformatics at
the center of the drug development programs. Research on the
interfaces of drug design chemistry and emerging fields like pro-
teomics, genomics and metabolomics will likely spur further
application of chemoinformatics techniques and some degree of
blurring of the previous distinctions between computational
domain specialties.
According to John Reynders, Informatics Officer, Discovery and
Development Informatics at Eli Lilly and Co. in Indianapolis, IN,
USA, the most desirable people are now those with a wide range of
skill in informatics, what he calls a ‘technology stack’ of software
development skills plus ‘meta-skills’, including the demonstrated
ability to work well in teams, to rapidly innovate in new areas, to
easily cross traditional boundaries, to learn domain specifics
quickly, and to apply techniques from one domain to another.
Reynders observes that in the rapidly-changing world of modern
life science, these abilities are often more important than extensive
training in one highly specialized area.
This implies that as well as training people as specialists in
chemoinformatics, we should also be training them as agile ‘infor-
maticians’, with the ability to cross over traditional boundary lines
when necessary. Encouragingly, Reynders says that diversity in
backgrounds and training is one of the great strengths of the
informatics staff at Lilly: ‘we have biologists cross-trained in soft-
ware development, software engineers with chemoinformatics
skills, formally trained bioinformaticians – this broad and eclectic
mix gives us great innovativeness and flexibility in what we do’.
This attitude has also been reflected elsewhere. In 2005, the IU
School of Informatics had the benefit of sound advice on educa-
tional programs from two outstanding groups of industry experts:
the members of our Science Informatics Advisory Board and the
external advisors for a recently received US National Institutes of
Health grant project for an exploratory center for cheminformatics
research. Again, it was highlighted that prospective industry
employees in scientific computing needed to have skills that go
beyond the traditionally instilled academic ones, including
change management, negotiation skills, modeling and statistics,
project management and generalized data-mining.
There seemed to be varying interest from industry in external
chemoinformatics education programs. Some reported little inter-
est in prepackaged educational modules, but greater interest in
short, intensive courses. We were advised to develop an industry-
exchange program to keep a finger on the pulse of industry. One
suggestion was to have IU staff work in industry for a couple of
weeks (or even have faculty spend a sabbatical there); alternatively,
we could have private sector workers come to IU to present
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industry professionals must take into account the competing time-
demands on students, and it is still unclear how this works best in
practice (e.g. should students be required to commit time to the
course during normal working hours?).
We consider distance education to be an essential part of any
successful chemoinformatics program in the coming years. The
great advantage of using distance education is that students do not
have to relocate to take a course, and thus the potential exists for a
small number of institutions to resource chemoinformatics learn-
ing around the world. Experiments in distance education at Indi-
ana University are, at the time of writing, looking very promising.
Online and telephone conferencing technologies now permit easy
participation in live lectures by students regardless of location, and
even allow more flexibility than traditional classroom courses
(enabling guests to lecture without traveling, teleconferenced
panel discussions and so on). Asynchronous technologies such
as the Sakai-based university course repositories (www.sakaipro-
ject.org) permit the sharing of documents and interaction between
students and lecturers outside of live classes.The ScienceDire
ScienceDirect’s extensive and unique full-text collection covers more than
the full suite of Trends, Current Opinion and Drug Discovery Today jou
unsurpassed searching and linking function
The rapid growth of the ScienceDirect collection is a result of the
addition to the Backfiles – heritage collections in a number of dis
of Elsevier’s journals back to volume one, issue one, is the addition
Also available online for the first time are six Cell titles’ long-aw
highlight important historic developm
For more information, visitChallenges
Thus the biggest current challenges for those of us involved in
chemoinformatics education are to appropriately define the scope
of chemoinformatics (particularly with relation to emerging dis-
ciplines such as chemogenomics, systems biology and proteo-
mics), to contextualize it in wider training in transferable
informatics skills, and to steer the development of courses and
programs now so that they will meet the educational needs in the
next 2–5 years. Currently, demand for graduate chemoinformatics
education at the MS level is fairly small, with the programs men-
tioned in this article typically attracting only a handful of students
each year. However, we do see a much greater interest in short
courses and certificate programs that can enable industry profes-
sionals to get ‘up to speed’ with the state of the art, and we expect
demand for these kinds of programs to grow in the coming years.
Whether increasing visibility of chemoinformatics will encourage
more students to choose a more involved Masters or PhD program
remains to be seen. What is clear, is that chemoinformatics is now
established as an essential ingredient of modern drug discovery
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